Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaishri Blakeley

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and gliomaJordi Rodon, Michael A Carducci, Juan M Sepulveda-Sánchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2021
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO GuidelineNimish A Mohile, Hans Messersmith, Na Tosha Gatson, et al.
Acta Neuropathologica Communications|August 30, 2019
Telomere alterations in neurofibromatosis type 1-associated solid tumorsFausto J Rodriguez, Mindy K Graham, Jacqueline A Brosnan-Cashman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform NeurofibromasBrian D Weiss, Pamela L Wolters, Scott R Plotkin, et al.
Neurosurgery|February 27, 2026
Clinical Outcomes Following Surgical Resection for Patients With Malignant Peripheral Nerve Sheath TumorsMelanie Alfonzo Horowitz, Jawad M Khalifeh, Xinlan Yang, et al.
Acta Neuropathologica|October 7, 2020
Epigenomic, genomic, and transcriptomic landscape of schwannomatosisSheila Mansouri, Suganth Suppiah, Yasin Mamatjan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2D Gareth Evans, Michel Kalamarides, Kim Hunter-Schaedle, et al.
Neuro-Oncology Practice|July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiativeLinda Dirven, Maartje E Vos, Tobias Walbert, et al.
Neuro-Oncology|January 14, 2025
Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial DesignRupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 20, 2021
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendationEric Legius, Ludwine Messiaen, Pierre Wolkenstein, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and gliomaJordi Rodon, Michael A Carducci, Juan M Sepulveda-Sánchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2021
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO GuidelineNimish A Mohile, Hans Messersmith, Na Tosha Gatson, et al.
Acta Neuropathologica Communications|August 30, 2019
Telomere alterations in neurofibromatosis type 1-associated solid tumorsFausto J Rodriguez, Mindy K Graham, Jacqueline A Brosnan-Cashman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform NeurofibromasBrian D Weiss, Pamela L Wolters, Scott R Plotkin, et al.
Neurosurgery|February 27, 2026
Clinical Outcomes Following Surgical Resection for Patients With Malignant Peripheral Nerve Sheath TumorsMelanie Alfonzo Horowitz, Jawad M Khalifeh, Xinlan Yang, et al.
Acta Neuropathologica|October 7, 2020
Epigenomic, genomic, and transcriptomic landscape of schwannomatosisSheila Mansouri, Suganth Suppiah, Yasin Mamatjan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2D Gareth Evans, Michel Kalamarides, Kim Hunter-Schaedle, et al.
Neuro-Oncology Practice|July 19, 2021
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiativeLinda Dirven, Maartje E Vos, Tobias Walbert, et al.
Neuro-Oncology|January 14, 2025
Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial DesignRupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 20, 2021
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendationEric Legius, Ludwine Messiaen, Pierre Wolkenstein, et al.
Pageof 6